Boosting Doxorubicin‐Induced Mitochondria Apoptosis for the Monodrug‐Mediated Combination of Chemotherapy and Chemodynamic Therapy
Author:
Affiliation:
1. School of Biomedical Engineering Anhui Medical University Hefei 230032 China
2. Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry Wuhan University Wuhan 430072 China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Pharmaceutical Science,Biomedical Engineering,Biomaterials
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202202045
Reference45 articles.
1. Cancer nanomedicine: progress, challenges and opportunities
2. A comprehensive review on time-tested anticancer drug doxorubicin
3. Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments
4. An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL
5. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy;Biomaterials;2024-09
2. ROS-responsive core–shell nano-inhibitor impedes pyruvate metabolism for reinforced photodynamic therapy and interrupted pre-metastatic niche formation;Acta Biomaterialia;2024-07
3. Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism;Journal of Nanobiotechnology;2024-06-08
4. EGCG-vanadium nanomedicine with neutral pH Fenton reaction activity inhibits heat shock proteins for enhanced photothermal/chemodynamic therapy;International Journal of Biological Macromolecules;2024-06
5. A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma;Advanced Healthcare Materials;2024-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3